Gyre TherapeuticsGYRE
13F holders, Q3 2025 (September 30)48holders
10new positions
10sold out
1famous investor
$7.46avg. 13F price*
At the end of Q3 2025, 48 institutions reported holding Gyre Therapeutics Inc. (GYRE) in their 13F filings, unchanged from Q2 2025. 10 opened new positions and 10 sold out. The largest holders were Vanguard Group Inc. ($8.6M), BlackRock, Inc. ($4.9M) and Geode Capital Management, LLC ($2.8M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Gyre Therapeutics Inc.
- CUSIP
- 403783103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $659K |
| Exits | 10 | $591K |
All 13F filers, Q2 2025 → Q3 2025: 128,148 shares bought and 442,233 shares sold, net −314,085 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Vanguard Group Inc. | 0.00% | Add +0.1% | 1,150,559 | $8.6M |
| BlackRock, Inc. | 0.00% | Reduce -21.7% | 659,397 | $4.9M |
| Geode Capital Management, LLC | 0.00% | Reduce -6.7% | 374,620 | $2.8M |
| State Street Corp. | 0.00% | Add +2.8% | 182,753 | $1.4M |
| SBI Securities Co., Ltd. | 0.03% | Reduce -27.7% | 167,866 | $1.3M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -4.7% | 123,386 | $920K |
| Northern Trust Corp. | 0.00% | Reduce -18.8% | 116,342 | $868K |
| State of Wisconsin Investment Board | 0.00% | Add +3.5% | 39,000 | $291K |
| Millennium Management | 0.00% | New | 35,751 | $267K |
| Bank of New York Mellon Corp | 0.00% | Add +1.7% | 24,398 | $182K |
| UBS Group AG | 0.00% | Add +165.8% | 22,962 | $171K |
| Alliancebernstein L.P. | 0.00% | Add +9.5% | 21,830 | $163K |
| STRS Ohio | 0.00% | Add +58.6% | 21,100 | $157K |
| Goldman Sachs Group Inc. | 0.00% | New | 18,034 | $135K |
| Lazard Asset Management LLC | 0.00% | New | 14,932 | $111K |
| Rhumbline Advisers | 0.00% | Reduce -17.0% | 13,432 | $100K |
| Barclays PLC | 0.00% | Reduce -44.2% | 13,396 | $100K |
| Jane Street Group, LLC | 0.00% | New | 12,958 | $97K |
| Royal Bank of Canada | 0.00% | Add +97.9% | 12,395 | $92K |
| Deutsche Bank AG | 0.00% | No change | 10,927 | $82K |
| FMR LLC | 0.00% | Reduce -6.3% | 10,204 | $76K |
| Morgan Stanley | 0.00% | Reduce -74.5% | 8,981 | $67K |
| Bank of America Corp. | 0.00% | Add +6.5% | 6,687 | $50K |
| Wells Fargo & Company | 0.00% | Reduce -20.8% | 5,558 | $41K |
| State of Alaska, Department of Revenue | 0.00% | New | 5,219 | $38K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -43.3% | 4,203 | $31K |
| JPMorgan Chase & Co. | 0.00% | Reduce -42.8% | 3,694 | $28K |
| New York State Common Retirement Fund | 0.00% | No change | 2,700 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +26.8% | 2,694 | $20K |
| BNP Paribas Financial Markets | 0.00% | Add +66.9% | 2,163 | $16K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | No change | 2,097 | $16K |
| Russell Investments Group, Ltd. | 0.00% | New | 1,124 | $8K |
| Legal & General Group Plc | 0.00% | Reduce -43.2% | 860 | $6K |
| California State Teachers Retirement System | 0.00% | Add +0.1% | 848 | $6K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 683 | $5K |
| Activest Wealth Management | 0.00% | No change | 533 | $4K |
| Citigroup Inc. | 0.00% | Reduce -93.5% | 384 | $3K |
| Amalgamated Bank | 0.00% | No change | 241 | $2K |
| Optiver Holding B.V. | 0.00% | New | 222 | $2K |
| Simplex Trading, LLC | 0.00% | New | 164 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | Add +72.9% | 102 | $761 |
| Principal Securities, Inc. | 0.00% | No change | 85 | $634 |
| Advisory Services Network, LLC | 0.00% | New | 66 | $492 |
| Arax Advisory Partners | 0.00% | New | 57 | $426 |
| Osaic Holdings, Inc. | 0.00% | No change | 38 | $283 |
| Sterling Capital Management LLC | 0.00% | Reduce -33.3% | 22 | $164 |
| Cwm, LLC | 0.00% | Reduce -65.0% | 43 | $0 |
| Covestor Ltd | 0.00% | No change | 6 | $0 |
"% of holder's portfolio" is GYRE's weight in each manager's 13F, not the share of Gyre Therapeutics Inc. the manager owns.